KYTHERA Biopharmaceuticals acquired by Allergan
Allergan agreed to acquire KYTHERA Biopharmaceuticals, a life sciences medical aesthetics brand, on Jun 17, 2015.
Transaction summary
- Target
- KYTHERA Biopharmaceuticals
- Acquirer
- Allergan
- Seller
- -
- Announced
- 2015-06-17
- Geography
- -
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
100% enterprise value
USD 2.1B
100% enterprise value | USD
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Amounts paid and other reported values
Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.
Consideration: USD 2.1B
Google News result headline from Genetic Engineering and Biotechnology News states 'Allergan to Acquire Kythera for $2.1B'; full article was not fetched. Pasted spreadsheet also lists size as 2.1, consistent with $2.1B.
Basis
- Reported consideration: USD 2.1bn.
Source summary
Allergan to Acquire KYTHERA Biopharmaceuticals - GlobeNewswire
ConfirmedContinue your research
Related transaction comps
ZELTIQ Aesthetics acquired by Allergan
2017-02-13 · Confirmed
View transaction → BiotechITM Isotope Technologies Munich SE acquired by Telix Pharmaceuticals Limited
2026-09-20 · Confirmed
View transaction → BiotechAtaiBeckley acquired by Eli Lilly and Company
2026-09-11 · Confirmed
View transaction → BiotechDersimelagon rights acquired by LEO Pharma
2026-08-18 · Confirmed
View transaction →